 Anip Bansal
Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Failure, Chronic | 4 | 2014 | 570 | 0.900 |
Why?
| | Renal Dialysis | 4 | 2014 | 435 | 0.780 |
Why?
| | Acute Kidney Injury | 7 | 2025 | 815 | 0.730 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2025 | 617 | 0.730 |
Why?
| | Metabolic Syndrome | 1 | 2025 | 354 | 0.720 |
Why?
| | Kidney Diseases | 1 | 2025 | 408 | 0.700 |
Why?
| | Ferritins | 2 | 2014 | 64 | 0.550 |
Why?
| | Anemia, Hemolytic, Autoimmune | 1 | 2014 | 14 | 0.450 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2014 | 58 | 0.420 |
Why?
| | Cisplatin | 2 | 2025 | 320 | 0.390 |
Why?
| | Bone Diseases, Metabolic | 1 | 2012 | 63 | 0.370 |
Why?
| | Iron | 1 | 2014 | 313 | 0.370 |
Why?
| | Obesity | 1 | 2025 | 2992 | 0.370 |
Why?
| | Hospital Mortality | 5 | 2021 | 911 | 0.340 |
Why?
| | Myocardial Infarction | 1 | 2014 | 1046 | 0.260 |
Why?
| | Calcium | 1 | 2012 | 1199 | 0.250 |
Why?
| | gamma-Glutamyl Hydrolase | 1 | 2025 | 3 | 0.240 |
Why?
| | Magnesium | 1 | 2025 | 156 | 0.230 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2025 | 94 | 0.230 |
Why?
| | Intensive Care Units | 5 | 2021 | 827 | 0.220 |
Why?
| | Methotrexate | 1 | 2025 | 260 | 0.210 |
Why?
| | Terminology as Topic | 1 | 2025 | 216 | 0.210 |
Why?
| | Inappropriate ADH Syndrome | 1 | 2023 | 8 | 0.210 |
Why?
| | Hyponatremia | 1 | 2023 | 42 | 0.200 |
Why?
| | Diabetic Nephropathies | 1 | 2025 | 294 | 0.180 |
Why?
| | Running | 1 | 2023 | 230 | 0.170 |
Why?
| | Critical Illness | 3 | 2021 | 811 | 0.160 |
Why?
| | Renal Replacement Therapy | 1 | 2020 | 92 | 0.160 |
Why?
| | Administration, Intravenous | 2 | 2025 | 155 | 0.160 |
Why?
| | Dialysis Solutions | 1 | 2019 | 21 | 0.160 |
Why?
| | Middle Aged | 13 | 2025 | 33479 | 0.160 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 73 | 0.150 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.140 |
Why?
| | Risk Factors | 4 | 2025 | 10388 | 0.140 |
Why?
| | Disease Progression | 1 | 2025 | 2757 | 0.140 |
Why?
| | Kidney | 1 | 2025 | 1468 | 0.130 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 318 | 0.130 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2021 | 301 | 0.130 |
Why?
| | Heart Arrest | 1 | 2020 | 339 | 0.130 |
Why?
| | Insulin Resistance | 1 | 2025 | 1208 | 0.130 |
Why?
| | Pyrazoles | 1 | 2019 | 423 | 0.120 |
Why?
| | Humans | 19 | 2025 | 137585 | 0.120 |
Why?
| | Pyrimidines | 1 | 2019 | 470 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.120 |
Why?
| | Critical Care | 1 | 2020 | 601 | 0.120 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 804 | 0.120 |
Why?
| | Pericardiocentesis | 1 | 2014 | 9 | 0.110 |
Why?
| | Colchicine | 1 | 2014 | 24 | 0.110 |
Why?
| | Oliguria | 1 | 2014 | 2 | 0.110 |
Why?
| | Hematinics | 1 | 2014 | 22 | 0.110 |
Why?
| | Pericardial Effusion | 1 | 2014 | 19 | 0.110 |
Why?
| | Aged | 8 | 2025 | 23961 | 0.110 |
Why?
| | Intra-Abdominal Hypertension | 1 | 2014 | 6 | 0.110 |
Why?
| | Cohort Studies | 5 | 2024 | 5742 | 0.110 |
Why?
| | Antineoplastic Agents | 1 | 2025 | 2129 | 0.110 |
Why?
| | Asymptomatic Diseases | 1 | 2014 | 89 | 0.110 |
Why?
| | Hypotension | 1 | 2014 | 122 | 0.100 |
Why?
| | Hemodialysis Solutions | 1 | 2012 | 3 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2014 | 250 | 0.090 |
Why?
| | Parathyroid Hormone | 1 | 2012 | 108 | 0.090 |
Why?
| | Glomerulonephritis | 1 | 2012 | 47 | 0.090 |
Why?
| | Up-Regulation | 1 | 2014 | 843 | 0.090 |
Why?
| | Complement C3 | 1 | 2012 | 209 | 0.090 |
Why?
| | Quality Improvement | 1 | 2019 | 1178 | 0.090 |
Why?
| | Aluminum | 1 | 2011 | 42 | 0.090 |
Why?
| | Adult | 9 | 2025 | 37929 | 0.090 |
Why?
| | Female | 10 | 2025 | 73304 | 0.090 |
Why?
| | Calcinosis | 1 | 2012 | 235 | 0.080 |
Why?
| | Male | 11 | 2025 | 67762 | 0.080 |
Why?
| | Neoplasms | 1 | 2025 | 2671 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2057 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2024 | 15657 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2012 | 546 | 0.070 |
Why?
| | Biomarkers | 2 | 2014 | 4149 | 0.060 |
Why?
| | Neutropenia | 1 | 2025 | 146 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2021 | 10811 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2020 | 7635 | 0.050 |
Why?
| | Time Factors | 1 | 2014 | 6828 | 0.050 |
Why?
| | Diuretics | 1 | 2023 | 74 | 0.050 |
Why?
| | Vasopressins | 1 | 2023 | 64 | 0.050 |
Why?
| | Risk Assessment | 2 | 2024 | 3457 | 0.050 |
Why?
| | Creatinine | 1 | 2024 | 499 | 0.050 |
Why?
| | Pandemics | 2 | 2020 | 1639 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2025 | 1353 | 0.050 |
Why?
| | Prone Position | 1 | 2021 | 30 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2021 | 43 | 0.040 |
Why?
| | Organ Dysfunction Scores | 1 | 2021 | 48 | 0.040 |
Why?
| | Hospitalization | 2 | 2021 | 2199 | 0.040 |
Why?
| | Early Medical Intervention | 1 | 2021 | 57 | 0.040 |
Why?
| | Patient Positioning | 1 | 2021 | 67 | 0.040 |
Why?
| | Hospitals, University | 1 | 2019 | 182 | 0.040 |
Why?
| | United States | 3 | 2020 | 14841 | 0.040 |
Why?
| | Mortality | 1 | 2021 | 362 | 0.040 |
Why?
| | Piperidines | 1 | 2019 | 206 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1266 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 786 | 0.030 |
Why?
| | Adenine | 1 | 2019 | 271 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2021 | 565 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2021 | 645 | 0.030 |
Why?
| | Anticoagulants | 1 | 2021 | 664 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1972 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2074 | 0.030 |
Why?
| | Young Adult | 2 | 2021 | 13209 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2804 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 3295 | 0.030 |
Why?
| | Glomerulonephritis, Membranous | 1 | 2012 | 2 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 21513 | 0.020 |
Why?
| | Acute Disease | 1 | 2012 | 1007 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4565 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1483 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2828 | 0.010 |
Why?
|
|
Bansal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|